glp-1 and cancer GLP-1RA thyroid cancer: New study suggests detection bias, not causation Could GLP-1 medications help slow
Description
These effects typically peak during dose titration and improve over time but cause 20-50 percent of patients to discontinue treatment within the first year
Lose It!: Lose It
Available from: Hamed K, Alosaimi MN, Ali BA, Alghamdi A, Alkhashi T, Alkhaldi SS, et al
Immunology (2010) 129:15469
J Endocrinol (2009) 202(3):4319
:max_bytes(150000):strip_icc()/VWHealth-Could-GLP-1Drugs-Reduce-Obesity-Related-Cancers-in-the-Future-3-7d602ab39c0448ddb00cd91b06be2a84.jpg)
Important Program Disclaimer
